A role for corticotropin releasing factor and urocortin in behavioral responses to stressors

Brain Research

Volumn 848, Issue 1-2, 1999, Pages 141-152

  Koob, George F ^a   Heinrichs, Stephen C ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BOSTON COLLEGE   (United States)

Author keywords

Anxiety; Corticotropin releasing factor; Drug addiction; Stress; Urocortin

Indexed keywords

ALCOHOL; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; NEUROPEPTIDE; UROCORTIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; BEHAVIOR; BRAIN; CONTROLLED STUDY; DRUG DEPENDENCE; FEEDING; FOOD INTAKE; HYPOTHALAMUS; INTRACEREBRAL DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCUS CERULEUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; STRESS; STRIA TERMINALIS; THALAMUS MIDLINE NUCLEUS;

EID: 0033457357     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01991-5     Document Type: Article

References (123)

1. Ahmed S.H., Koob G.F. Transition from moderate to excessive drug intake: change in hedonic set point. Science. 282:1998;298-300.
2. Aldenhoff J.B., Gruol D.L., Rivier J., Vale W., Siggins G.R. Corticotropin-releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science. 221:1983;875-877.
3. Alonso G., Szafarczyk A., Balmefrezol M., Assenmacher I. Immunocytochemical evidence for stimulatory control by ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin-releasing hormone and vasopressin in rats. Brain Res. 397:1986;297-307.
4. Arase K., York D.A., Shimizu H., Shargill N., Bray G.A. Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats. Am. J. Physiol. 255:1988;E255-E259.
5. Asakawa A., Inui A., Ueno N., Makino S., Fujino M.A., Kasuga M. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology. 116:1999;1287-1292.
6. H.A. Baldwin, K.T. Britton, G.F. Koob, Behavioral effects of corticotropin-releasing factor, in: D.W. Pfaff, D. Ganten (Eds.), Behavioral Aspects of Neuroendocrinology (series title: Current Topics in Neuroendocrinology, vol. 10), Springer-Verlag, Berlin, 1990, pp. 1-14.
7. Baldwin H.A., Rassnick S., Rivier J., Koob G.F., Britton K.T. CRF antagonist reverses the 'anxiogenic' response to ethanol withdrawal in the rat. Psychopharmacology. 103:1991;227-232.
8. Baram T.Z., Chalmers D.T., Chen C., Koutsoukos Y., De Souza E.B. The CRF1 receptor mediates the excitatory actions of corticotropin-releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res. 770:1997;89-95.
9. Bell S.M., Reynolds J.G., Thiele T.E., Gan J., Figlewicz D.P., Woods S.C. Effects of third intracerebroventricular injections of corticotropin-releasing factor (CRF) on ethanol drinking and food intake. Psychopharmacology. 139:1998;128-135.
10. Berridge C.W., Dunn A.J. Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice. Regul. Pept. 16:1986;83-93.
11. Berridge C.W., Dunn A.J. A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice. Horm. Behav. 21:1987;393-401.
12. Biro E., Sarnyai Z., Penke B., Szabo G., Telegdy G. Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats. Neuroendocrinology. 57:1993;340-345.
13. Bloom F.E., Battenberg E.L., Rivier J., Vale W. Corticotropin-releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus. Regul. Pept. 4:1982;43-48.
14. Britton D.R., Koob G.F., Rivier J., Vale W. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci. 31:1982;363-367.
15. Britton D.R., Varela M., Garcia A., Rosenthal M. Dexamethasone suppresses pituitary-adrenal but not behavioral effects of centrally administered CRF. Life Sci. 38:1986;211-216.
16. Burchfield S. The stress response: a new perspective. Psychosom. Med. 41:1979;661-672.
17. Butler P.D., Weiss J.M., Stout J.C., Kilts C.D., Cook L.L., Nemeroff C.B. Corticotropin-releasing factor produces anxiogenic and behavioral activating effects following microinfusion into the locus coereuleus. Neurosci. Abstr. 14:1988;288.
18. Cador M., Ahmed S.H., Koob G.F., Le Moal M., Stinus L. Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role. Brain Res. 597:1992;304-309.
19. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350.
20. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., Nemeroff C.B. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J. Neurosci. 6:1986;2908-2914.
21. Chen M.F., Chiu T.H., Lee E.H.Y. Noradrenergic mediation of the memory-enhancing effect of corticotropin-releasing factor in the locus coeruleus of rats. Psychoneuroendocrinology. 17:1992;113-124.
22. Cole B.J., Britton K.T., Koob G.F. Central administration of alpha-helical corticotropin-releasing factor attenuates the acquisition of a conditioned emotional response. Neurosci. Abstr. 13:1987;427.
23. Cole B.J., Cador M., Stinus L., Rivier J., Vale W., Koob G.F., Le Moal M. Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization. Brain Res. 512:1990;343-346.
24. Cole B.J., Koob G.F. Propranolol antagonizes the enhanced conditioned fear produced by corticotropin releasing factor. J. Pharmacol. Exp. Ther. 247:1988;902-910.
25. Contarino A., Dellu F., Koob G.F., Smith G.W., Lee K.-F., Vale W., Gold L.H. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. Brain Res. 835:1999;1-9.
26. Cummings S., Elde R., Ells J., Lindall A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J. Neurosci. 3:1983;1355-1368.
27. Curtis A.L., Grigoriadis D.E., Page M.E., Rivier J., Valentino R.J. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies. J. Pharmacol. Exp. Ther. 268:1994;359-365.
28. Curtis A.L., Lechner S.M., Pavcovich L.A., Valentino R.J. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J. Pharmacol. Exp. Ther. 281:1997;163-172.
29. Dagnault A., Ouerghi D., Richard D. Treatment with alpha-helical-CRF (9-41) prevents the anorectic effect of 17-beta-estradiol. Brain Res. Bull. 32:1993;689-692.
30. De Pedro N., Alonso-Gomez A.L., Gancedo B., Delgado M.J., Alonso-Bedate M. Role of corticotropin-releasing factor (CRF) as a food intake regulator in goldfish. Physiol. Behav. 53:1993;517-520.
31. De Souza E.B. Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution. J. Neurosci. 7:1987;88-100.
32. Diamant M., Croiset G., De Weid D. The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats. Peptides. 13:1992;1149-1158.
33. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15:1990;71-100.
34. Eaves M., Thatcher-Britton K., Rivier J., Vale W., Koob G.F. Effects of corticotropin-releasing factor on locomotor activity in hypophysectomized rats. Peptides. 6:1985;923-926.
35. Ehlers C.L., Henriksen S.J., Wang M., Rivier J., Vale W., Bloom F.E. Corticotropin-releasing factor produces increases in brain excitability and convulsive seizures in the rat. Brain Res. 278:1983;332-336.
36. Erb S., Shaham Y., Stewart J. Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology. 128:1996;408-412.
37. Fazal N., Slominski A., Choudhry M.A., Wei E.T., Sayeed M.M. Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett. 435:1998;187-190.
38. L.A. Fisher, Central actions of corticotropin-releasing factor on autonomic nervous activity and cardiovascular functioning, in: D.J. Chadwick, J. Marsh, K. Ackrill (Eds.), Corticotropin-Releasing Factor (series title: Ciba Foundation Symposium, vol. 172), Wiley-Liss, New York, 1993, pp. 243-257.
39. Gawin F.H., Kleber H.D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Arch. Gen. Psychiatry. 43:1986;107-113.
40. Gray T.S., Magnuson D.J. Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat. J. Comp. Neurol. 262:1987;365-374.
41. Heinrichs S.C., Britton K.T., Koob G.F. Both conditioned taste preference and aversion induced by corticotropin-releasing factor. Pharmacol. Biochem. Behav. 40:1991;717-721.
42. Heinrichs S.C., Cole B.J., Pich E.M., Menzaghi F., Koob G.F., Hauger R.L. Endogenous corticotropin-releasing factor modulates feeding induced by neuropeptide Y or a tail pinch stressor. Peptides. 13:1992;879-884.
43. Heinrichs S.C., Koob G.F. Corticotropin-releasing factor modulates dietary preference in nutritionally and physically stressed rats. Psychopharmacology. 109:1992;177-184.
44. Heinrichs S.C., Menzaghi F., Merlo-Pich E., Baldwin H.A., Rassnick S., Britton K.T., Koob G.F. Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity. Neuropsychopharmacology. 11:1994;179-186.
45. Heinrichs S.C., Menzaghi F., Pich E.M., Hauger R.L., Koob G.F. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res. 611:1993;18-24.
46. Heinrichs S.C., Menzaghi F., Schulteis G., Koob G.F., Stinus L. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav. Pharmacol. 6:1995;74-80.
47. Heinrichs S.C., Pich E.M., Miczek K., Britton K.T., Koob G.F. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res. 581:1992;190-197.
48. J.W. Hennessy, S. Levine, Stress, arousal, and the pituitary-adrenal system: a psychoendocrine hypothesis, in: J.M. Sprague, A.N. Epstein (Eds.), Progress in Psychobiology and Physiological Psychology, 8th ed., Academic Press, New York, 1979, pp. 133-178.
49. Jones D.N., Kortekaas R., Slade P.D., Middlemiss D.N., Hagan J.J. The behavioural effects of corticotropin-releasing factor-related peptides in rats. Psychopharmacology. 138:1998;124-132.
50. Kalin N.H., Sherman J.E., Takahashi L.K. Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats. Brain Res. 457:1988;130-135.
51. G.F. Koob, Corticotropin-releasing factor, norepinephrine and stress, Biol. Psychiatry (1999), in press.
52. Koob G.F., Bloom F.E. Corticotropin-releasing factor and behavior. Federation Proc. 44:1985;259-263.
53. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
54. Koob G.F., Cador M. Psychomotor stimulant sensitization: the corticotropin-releasing factor-steroid connection. Behav. Pharmacol. 4:1993;351-354.
55. Koob G.F., Heinrichs S.C., Menzaghi F., Merlo-Pich E., Britton K.T. Corticotropin-releasing factor, stress and behavior. Seminars Neurosci. 6:1994;221-229.
56. Koob G.F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 278:1997;52-58.
57. Koob G.F., Markou A., Weiss F., Schulteis G. Opponent process and drug dependence: neurobiological mechanisms. Seminars Neurosci. 5:1993;351-358.
58. Koob G.F., Swerdlow N., Seeligson M., Eaves M., Sutton R., Rivier J., Vale W. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation. Neuroendocrinology. 39:1984;459-464.
59. Korte S.M., Korte-Bouws G.A.H., Bohus B., Koob G.F. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats. Physiol. Behav. 56:1994;115-120.
60. Kozicz T., Yanaihara H., Arimura A. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J. Comp. Neurol. 391:1998;1-10.
61. Krahn D.D., Gosnell B.A., Grace M., Levine A.S. CRF antagonist partially reverses CRF- and stress-induced effects on feeding. Brain Res. Bull. 17:1986;285-289.
62. Krahn D.D., Gosnell B.A., Levine A.S., Morley J.E. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res. 443:1988;63-69.
63. M.J. Kreek, Multiple drug abuse patterns and medical consequences, in: H.Y. Meltzer (Ed.), Psychopharmacology: The Third Generation of Progress, Raven Press, New York, 1987, pp. 1597-1604.
64. Kreek M.J., Ragunath J., Plevy S., Hamer D., Schneider B., Hartman N. ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans. Neuropeptides. 5:1984;277-278.
65. Lechner S.M., Curtis A.L., Brons R., Valentino R.J. Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res. 756:1997;114-124.
66. Lee Y., Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J. Neurosci. 17:1997;6434-6446.
67. Lee E.H.Y., Tsai M.J. The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropin-releasing factor in mice. Behav. Neural Biol. 51:1989;412-423.
68. Liang K.C., Lee E.H.Y. Intra-amygdala injections of corticotropin-releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology. 96:1988;232-236.
69. Liang K.C., Melia K.R., Miserendino M.J., Falls W.A., Campeau S., Davis M. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex. J. Neurosci. 12:1992;2303-2312.
70. Liebsch G., Landgraf R., Engelmann M., Lorscher P., Holsboer F. Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain. J. Psychiatric Res. 33:1999;153-163.
71. Liposits Z., Phelix C., Paull W.K. Synaptic interaction of serotonergic axons and corticotropin-releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat: a light and electron microscopic immunocytochemical study. Histochemistry. 86:1987;541-549.
72. Marrosu F., Mereu G., Fratta W., Carcangiu P., Camarri F., Gessa G.L. Different epileptogenic activities of murine and ovine corticotropin-releasing factor. Brain Res. 408:1987;394-398.
73. Menzaghi F., Heinrichs S.C., Pich E.M., Tilders F.J.H., Koob G.F. Functional impairment of hypothalamic corticotropin-releasing factor neurons with immunotargeted toxins enhances food intake induced by neuropeptide Y. Brain Res. 618:1993;76-82.
74. Menzaghi F., Howard R.L., Heinrichs S.C., Vale W., Rivier J., Koob G.F. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats. J. Pharmacol. Exp. Ther. 269:1994;564-572.
75. Merali Z., McIntosh J., Kent P., Michaud D., Anisman H. Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J. Neurosci. 18:1998;4758-4766.
76. Merlo-Pich E., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G.F., Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15:1995;5439-5447.
77. Moreau J.L., Kilpatrick G., Jenck F. Urocortin, a novel neuropeptide with anxiogenic-like properties. Neuroreport. 8:1997;1697-1701.
78. Pacak K., McCarty R., Palkovits M., Kopin I.J., Goldstein D.S. Effects of immobilization on in vivo release of norepinephrine in the bed nucleus of the stria terminalis in conscious rats. Brain Res. 688:1995;242-246.
79. Pacak K., Palkovits M., Kopin I.J., Goldstein D.S. Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies. Front. Neuroendocrinol. 16:1995;89-150.
80. Parkes D.G., Vaughan J., Rivier J., Vale W., May C.N. Cardiac intropic actions of urocortin in conscious sheep. Am. J. Physiol. 272:1997;H2115-H2122.
81. Perrin M., Donaldson C., Chen R., Blount A., Berggren T., Bilezikjian L., Sawchenko P., Vale W. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. USA. 92:1995;2969-2973.
82. Perrin M.H., Donaldson C.J., Chen R., Lewis K.A., Vale W.W. Cloning and functional expression of a rat brain corticotropin-releasing factor (CRF) receptor. Endocrinology. 133:1993;3058-3061.
83. Phelix C.F., Liposits Z., Paull W.K. Catecholamine-CRF synaptic interaction in a septal bed nucleus: afferents of neurons in the bed nucleus of the stria terminalis. Brain Res. Bull. 33:1994;109-119.
84. Pich E.M., Koob G.F., Sattler S.C., Menzaghi F., Heilig M., Heinrichs S.C., Vale W., Weiss F. Stress-induced release of corticotropin-releasing factor in the amygdala measured by in vivo microdialysis. Neurosci. Abstr. 18:1992;535.
85. Raber J., Koob G.F., Bloom F.E. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling: comparison with the hypothalamic response. J. Pharmacol. Exp. Ther. 272:1995;815-824.
86. Radulovic J., Ruhmann A., Liepold T., Spiess J. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J. Neurosci. 19:1999;5016-5025.
87. Rassnick S., Heinrichs S.C., Britton K.T., Koob G.F. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605:1993;25-32.
88. Richter R.M., Weiss F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse. 32:1999;254-261.
89. Rodriguez de Fonseca F., Carrera M.R.A., Navarro M., Koob G.F., Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science. 276:1997;2050-2054.
90. Rosenthal M.J., Morley J.E. Corticotropin-releasing factor (CRF) and age-related differences in behavior of mice. Neurobiol. Aging. 10:1989;167-171.
91. Sajdyk T.J., Schober D.A., Gehlert D.R., Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav. Brain Res. 100:1999;207-215.
92. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., Telegdy G. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res. 675:1995;89-97.
93. Selye H. A syndrome produced by diverse noxious agents. Nature. 32:1936;138.
94. J. Sepinwall, L. Cook, Behavioral pharmacology of anti-anxiety drugs, in: L.L. Iversen, S.D. Iversen, S.H. Snyder (Eds.), Handbook of Psychopharmacology, vol. 13, Plenum Press, New York, 1978, pp. 345-393.
95. Sherman J.E., Kalin N.H. The effects of ICV-CRH on novelty-induced behavior. Pharmacol. Biochem. Behav. 26:1987;699-703.
96. Sherman J.E., Kalin N.H. ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity. Pharmacol. Biochem. Behav. 30:1988;801-807.
97. Sirinathsinghji D.J.S. Regulation of lordosis behavior in the female rat by corticotropin-releasing factor, beta-endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area. Brain Res. 375:1986;49-56.
98. Sirinathsinghji D.J.S., Rees L.H., Rivier J., Vale W. Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature. 305:1983;230-235.
99. Skutella T., Criswell H., Moy S., Probst J.C., Breese G.R., Jirikowski G.F., Holsboer F. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat. Neuroreport. 5:1994;2181-2185.
100. Skutella T., Montkowski A., Stohr T., Probst J.C., Landgraf R., Holsboer F., Jirikowski G.F. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats. Cell. Mol. Neurobiol. 14:1994;579-588.
101. Skutella T., Probst J.C., Renner U., Holsboer F., Behl C. Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety. Neuroscience. 85:1998;795-805.
102. Smagin G.N., Howell L.A., Ryan D.H., De Souza E.B., Harris R.B. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. Neuroreport. 9:1998;1601-1606.
103. Smagin G.N., Swiergiel A.H., Dunn A.J. Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex. Brain Res. Bull. 36:1995;71-76.
104. Smith G.W., Aubry J.-M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., Chen R., Marchuk Y., Hauser C., Bentley C.A., Sawchenko P.E., Koob G.F., Vale W., Lee K.-F. Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 20:1998;1093-1102.
105. Spina M., Merlo-Pich E., Chan R.K.W., Basso A.M., Rivier J., Vale W., Koob G.F. Appetitie-suppressing effects of urocortin, a CRF-related neuropeptide. Science. 273:1996;1561-1564.
106. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14:1994;2579-2584.
107. Sutton R.E., Koob G.F., Le Moal M., Rivier J., Vale W. Corticotropin-releasing factor (CRF) produces behavioural activation in rats. Nature. 297:1982;331-333.
108. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 36:1983;165-186.
109. Swerdlow N.R., Britton K.T., Koob G.F. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41). Neuropsychopharmacology. 2:1989;285-292.
110. Swerdlow N.R., Geyer M.A., Vale W.W., Koob G.F. Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology. 88:1986;147-152.
111. Swiergiel A.H., Takahashi L.K., Kalin N.H. Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res. 623:1993;229-234.
112. Swiergiel A.H., Takahashi L.K., Rubin W.W., Kalin N.H. Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats. Brain Res. 587:1992;263-268.
113. Takahashi L.K., Kalin N.H., Vanden Burgt J.A., Sherman J.E. Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats. Behav. Neurosci. 103:1989;648-654.
114. Tazi A., Dantzer R., Le Moal M., Rivier J., Vale W., Koob G.F. Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats. Regul. Pept. 18:1987;37-42.
115. Timpl P., Spanagel R., Sillaber I., Kreese A., Reul J.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nature Genet. 19:1998;162-166.
116. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and beta-endorphin. Science. 213:1981;1394-1397.
117. Valentino R.J., Foote S.L. Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons. Neuroendocrinology. 45:1987;28-36.
118. Valentino R.J., Foote S.L., Aston-Jones G. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res. 270:1983;363-367.
119. Valentino R.J., Foote S.L., Page M.E. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann. N.Y. Acad. Sci. 697:1993;173-188.
120. Valentino R.J., Page M.E., Curtis A.L. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res. 555:1991;25-34.
121. Van Bockstaele E.J., Colago E.E., Valentino R.J. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response. J. Neuroendocrinol. 10:1998;743-757.
122. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Sawchenko P.E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.
123. E.P. Zorrilla, G. Schulteis, A. Ormsby, A. Klaasen, N. Ling, J.R. McCarthy, G.F. Koob, E.B. De Souza, Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF-1 receptors, submitted for publication.